Document is current
Any future updates will be listed below
-
Authors
Shokati, Ameneh
Nikbakht, Mohsen https://orcid.org/0000-0001-6621-5424
Sahraian, Mohammad Ali
Saeedi, Roghayyeh
Asadollahzadeh, Elnaz
Rezaeimanesh, Nasim
Chahardouli, Bahram
Gharaylou, Zeinab
Mousavi, Seyed Asadollah
Ai, Jafar https://orcid.org/0000-0001-5083-2081
Naser Moghadasi, Abdorreza https://orcid.org/0000-0002-8598-0911
-
Funding
Funding for this research was provided by:
Multiple Sclerosis Research Center (1400-1-148-52617)
Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital (1400-1-233-51589)
Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital (1400-1-233-51589)
- License Information
-
More Information
Article History
Received: 12 October 2024
Accepted: 29 April 2025
First Online: 8 May 2025
Declarations
:
: The authors declare no competing interests.
: This study was conducted according to national ethical standards and laws and have been endorsed by the Ethics Committee at Tehran university of Medical Sciences. (Ref # IR.TUMS.HORCSCT.REC.1400.007).
: Not applicable.
